Standard Nuclear Stock (STDN) Since the IPO: Down 35% From $15 to $9.75

STDN closed at $9.75 on July 23, 2026 — down 35% from its $15 IPO price just a week earlier, and down 43% from the $845M-to-$3.55B valuation range the company pitched in its S-1. That's the short answer. The longer answer is more interesting.

Standard Nuclear filed its S-1 on July 7 chasing a $3.55 billion valuation. By the time it actually priced two weeks later, the company had already cut the offering roughly in half — 10 million shares at $15.00 instead of 18.25 million at $18–$21. Then it opened 10% below even that reduced price. What's happened since is a case study in how fast a hot-sector IPO can unwind once the market decides the story is ahead of the fundamentals.

What Is Standard Nuclear's Stock Price After the IPO?

Standard Nuclear (NYSE: STDN) closed at $9.75 on July 23, 2026, after trading between $8.82 and $9.85 intraday. That's down from a $15.00 IPO price on July 15 and a $12.30 first-day close on July 16 — a roughly 35% decline across one week of public trading, and a market cap that's fallen from $2.4 billion at pricing to approximately $1.55 billion.

Figures are July 2026 trading data blended from Investing.com, StockAnalysis.com, Yahoo Finance, and BusinessWire IPO pricing announcements. July 19 price is an estimated range from reported sector-wide percentage declines; exact closing prints for that date were not independently confirmed at publication.

The Standard Nuclear IPO: What Changed Between the S-1 and Pricing

Standard Nuclear's original S-1 filing targeted 18.3 million shares at $18–$21, aiming to raise up to $356 million at a fully diluted valuation near $3.7 billion. By pricing day on July 15, that had shrunk to 10 million shares at a flat $15.00 — a $150 million raise, well under half the original target dollar amount, and a headline valuation of roughly $2.4 billion instead of $3.55 billion.

A downsized, below-range IPO followed by a negative debut is a specific signal: underwriters (BofA Securities and Goldman Sachs led the book) couldn't find enough demand at the original terms and cut both the price and the share count to get the deal done at all. That's a very different setup than the typical hot-IPO pattern where a company prices conservatively to guarantee a first-day pop. Track how STDN compares to other 2026 listings on the IPO Tracker.

Why Did Standard Nuclear Stock Drop Since Its IPO?

Three things compounded at once. First, the offering itself signaled weak demand before the stock even opened. Second, STDN got caught in a sector-wide nuclear selloff that hit nearly every advanced-reactor and fuel name simultaneously — Oklo fell 15.8% for the week, NuScale dropped 14.6%, and X-energy, Nano Nuclear, and Uranium Energy Corp all lost 8-9% in a single session on July 16 as the VanEck Uranium and Nuclear ETF (NLR) slid 16% for the month. Third, STDN-specific reports of heightened regulatory scrutiny tied to reactor-safety questions added company-level pressure on top of the sector move, with the stock trading down as much as 14% in a single stretch on that news.

STDN's decline is more than double the sector average, which tells you the drop isn't purely macro. A brand-new IPO with $3.36 million in trailing revenue and no public trading history to anchor sentiment gets punished harder in a risk-off week than an established name like Oklo, which at least has years of price discovery and a larger investor base absorbing the selling. The utilities largely sat this out — Constellation Energy fell just 2% and Vistra actually rose 5% over the same stretch — underscoring that this was a growth-and-story selloff, not a broad energy-sector rotation.

Standard Nuclear Stock: Does the Drop Make the Valuation Math Better?

At the original $3.55 billion IPO target, Standard Nuclear was priced at roughly 1,050x its $3.36 million trailing-twelve-month revenue. At today's $1.55 billion market cap, that multiple has compressed to roughly 460x — still an extreme number by any conventional standard, but a materially different starting point for anyone evaluating the stock fresh rather than anchored to the S-1's headline figure.

The balance sheet is the one thing that hasn't gotten worse. Standard Nuclear raised $150 million in the IPO and reports roughly $125 million in cash on hand, against a Q1 2026 operating loss of $8.2 million and a gross loss of $4.4 million on just $593,802 of quarterly revenue. That funds several years of runway without needing to raise again, which matters for a pre-revenue-scale industrial company whose entire thesis depends on SMR developers actually placing large fuel orders over the next 3-5 years rather than the next two quarters.

What This Means for the Rest of the 2026 Nuclear IPO Pipeline

Standard Nuclear was supposed to be a proof point for the advanced-nuclear investment thesis translating into public-market appetite. Instead, its debut is a warning shot for the other pre-revenue nuclear and SMR names eyeing 2026-2027 listings: a compelling narrative around AI power demand and DOE policy tailwinds isn't automatically enough to clear a $2-3 billion valuation bar when a company is still reporting single-digit-million-dollar revenue. Underwriters on the next nuclear IPO will likely price more conservatively after watching STDN's book-building process force a near-50% cut to the raise before the stock even traded.

For investors, the more useful read isn't "nuclear is overhyped" — Constellation and Vistra's resilience during the same selloff argues against that — it's that the market is now differentiating sharply between profitable nuclear operators and pre-revenue nuclear-adjacent bets. That distinction didn't really exist six months ago, when nearly every ticker with "nuclear" or "SMR" in its story got bid up together. Compare how other 2026 debuts are trading on the Tech IPO dashboard.

How Standard Nuclear's Debut Compares to Other 2026 IPO Stumbles

STDN isn't the only 2026 listing that priced ambitiously and traded down hard once the story met a public order book. Cerebras (CBRS) fell from a $386 opening peak to under $170 before a further earnings-driven crash, and several AI-adjacent IPOs this year have followed a similar arc: strong pre-IPO narrative, aggressive S-1 valuation target, then a sharp reset once quarterly numbers or sector sentiment force a rerating. What sets Standard Nuclear apart is the speed — most of the 35% decline happened inside a single week of trading, not over several quarters, because the offering was already downsized going in and the sector selloff hit before the stock had time to build its own independent trading base.

There's a structural reason first-week volatility tends to run hotter for names like STDN: the free float is small (10 million shares, a fraction of the roughly 155-160 million shares outstanding on a fully diluted basis), trading volume in the first few sessions is dominated by short-term traders rather than long-only institutional holders who did diligence on the S-1, and there's no earnings history or analyst coverage yet to anchor a floor price. That combination — thin float, no anchor, and a sector already in a 16% monthly drawdown per the VanEck Uranium and Nuclear ETF — is close to a worst-case setup for a debut week, independent of whether the underlying TRISO fuel business is sound.

The Bottom Line on Standard Nuclear Stock

The Standard Nuclear IPO went from a $3.55 billion target to a $2.4 billion pricing to a $1.55 billion market cap in under three weeks. Some of that is a sector-wide nuclear selloff that also hit Oklo and NuScale. Some of it is company-specific — a downsized offering that never got a debut pop, plus reactor-safety headlines that added fresh regulatory risk on top of an already speculative story. None of it changes the underlying thesis: if advanced nuclear reactors get built in the US at scale over the next decade, someone has to supply the fuel, and Standard Nuclear remains the only domestic commercial-scale TRISO producer with a signed DOE agreement.

What changed is the price you're paying for that bet. At $9.75, the multiple is roughly half of what it was at the IPO target, and the $125 million cash balance buys time for the SMR order book to materialize. Whether that's enough to offset a first week of trading this rough depends on how the next few DOE funding milestones and reactor-customer contracts land — watch those before the next earnings print. Track STDN and the rest of the 2026 IPO class on the IPO Tracker.